Follow Us:Respiratio 2018; 8 (1-2):56-61
RESPIRATORNI ASPEKT DEKOMPENZOVANE CIROZE JETRE
THE RESPIRATORY ASPECT OF DECOMPENSATED LIVER CIRRHOSIS
Zoran Mavija¹, Milka Mavija¹, Božo Krivokuća¹, Goran Bokan², Nikola Malešević²
¹Univerzitetski klinički centar Republike Srpske, Banja Luka, Republike Srpska, Bosna i Hercegovina
² Medicinski fakultet Banja Luka, Univerzitet u Banjoj Luci, Banja Luka, Republike Srpska, Bosna i Hercegovina
Original research
Naučni članak
doi: 10.26601/rsp.aprs.18.7
Sažetak: Kod pacijenata sa dekompenzovanom cirozom jetre treba uvijek sagledati u potpunosti respiratorni aspekt prisutnih poremećaja. Ciroza jetre može da mijenja disajne funkcije dovodeći do promjena u pleuri i abdomenu, ili neposredno izazivajući patološke promjene u samim plućima.
Cilj rada je ispitati sve relevantne karakteristike respiratornog aspekta ciroze jetre i evaluisati osnovne parametre plućne funkcije. U ispitivanje je uključeno 60 pacijenata sa jasnim kliničkim manifestacijama dekompenzovane ciroze jetre. Gušenje kao dominantan simptom je bilo prisutno kod 31,60 % pacijenata. Hipoksemija je verifikovana kod 28,30%, dok je hipokapniju imalo 15% pacijenata. Alkaloza je bila prisutna kod 11,60% pacijenata i acidoza kod 3,30% cirotičnih pacijenata. Kod 8,30% pacijenata sa dekompenzovanom cirozom jetre dijagnostikovan je desnostrani pleuralni izliv, lijevostrani pleuralni izliv je bio prisutan u 3,30% pacijenata, a obostrani pleuralni izliv u 1,60 % ispitanika.
Respiratorni aspekt ima značajan uticaj na dekompenzovanu cirozu jetre, stoga je potrebno seriozno dijagnostikovati sve prisutne poremećaje.
Ključne riječi: ciroza jetre, respiratorni aspekt, poremećaji oksigenacije
LITERATURA
|
1. Ho V. Current concept in the management of hepatopulmonary syndrome. Vascu Health Risk Man 2008; 4:1035-41. |
|
|
|
|
|
2. Kennedy TC, Knudson RJ: Exercise aggravated hypoxemia and orthodeoxia in cirrhosis. Chest 1997; 72:305-9. |
|
|
|
|
|
3. Fukushima KY, Yatsuhashi H, Kinoshita A, Ueki T, Matsumoto T, Osumi M et al. Two cases of hepatopulmonary syndrome with improved liver fuction following long term oxygen therapy. J Gastroeneterol 2007; 42:176-.80. |
|
|
|
|
|
4. Fintz JS, Fallon MB, Kawut SM. Pulmonary vascular complications of Liver Disease. Am J Respir Care Med. Chest 2013:187;133-43. |
|
|
|
|
|
5. Argudeas MR, Singh H, Faulk DK, Fallon MB. Utility of pulse oximetry screening for hepatopulmonary syndrom. Clin Gastroenterol Hepatolo 2007: 5:749. |
|
|
|
|
|
6. Krowka MJ, Dickson ER, Cortese DA, Hepatopulmonary syndrome, Clinical observation and lack of therapeutic response to somatostatin analogue. Chest 1993; 104:515-21. |
|
|
|
|
|
7. Scott VL, Dodson SF, King Y. The hepatopulmonary syndrome. Surg Clin North Am 1999;79(1):23-41. |
|
|
|
|
|
8. Krowka MJ. Hepatopulmonary syndrome. Gut 2000; 46(1): 1-4. |
|
|
|
|
|
9. Agusti AGN, Roca J Bosch J, Rodriguez-Roisin R. The lung in patients with cirrhosis. J Hepatol 1990;10:251-57. |
|
|
|
|
|
10. Franchis R, Primignani M. Natural hystori of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001; 5:645-63. |
|
|
|
|
|
11. Alberts WM, Salem AJ, Solomon DA, Boyce G. Hepatic hydrothorax. Arch Int Med 1991;151:2383-88. |
|
|
|
|
|
12. Fussner LA, Iyer VN, Cartin-Ceba R, et al. Intrapulmonary vascular dilatation are commom in portopulmonary hypertension and may be associated with decreased survival. Liver transpl 2015; 21:1355. |
|
|
|
|
|
13. Abraldes JG, Tarantino I, Turnes J, et al. Hemodynamic response to pharmacologic treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology 2003; 37:902-08. |
|
|
|
|
|
14. Gorgy AI, Jonassaint NL, Stanley SE, et al. Hepatopulmonary syndrome is a frequent cause of dyspnea in telomere disordes. Chest 2015; 148:1019. |
|
|
|
|
|
15. Brussino L, Bucca C, Morrelo M, Scappaticci E, Mauro M, Rolla P. Effect on dyspnoea and hypoxaemia of inhaled NG-nitro-L-arginin methyl ester in hepatopulomary sindrome. Lancet 2003; 362:43-4. |
|
|
|
|
|
16. Hira HS, Kumar J, Tvagi SK, Jain SK. A study of hepatopulmoary syndrome among patients of cirrhosis of liver and portal hypertension. Indian J Chest Dis Allied Sci 2003; 45:165-71. |
|
|
|
|
|
17. Ier VN, Krasuski RA, et al. Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era. Hepatology 2013; 57:2427. |
|
|
|
|
|
18. Ferreira PP. Camara EJN, Paula RLP, Zollinger CC, Cavalcanti AR, Bittencourt PL. Prevalence of hepatopulmonary syndrome in patients with decompensated chronic liver disease and its impact on shorte-time survival. Arq Gastroenterol 2008; 45:34-7. |
|
|
|
|
|
19. Grace JA, Angus PW, Hepatopulmonary syndrome. Update on recent advances in pathophysiology, investigation, and treatment. J Gastroenterol Hepatol 2013;28-213. |
|
Mavija Zoran
Univerzitetski klinički centar Republike Srpske, Banja Luka
Klinika za unutrašnje bolesti
Tel : +387 51 342 660
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.